ORKA — Oruka Therapeutics, Inc.

$97.95+3.30%

Dividend YieldN/A

Annual DividendN/A

Payout Ratio

N/A

Consecutive Years0 yrs

FrequencyN/A

Next Ex-Date

N/A

1-Year Growth

N/A

3-Year Growth

N/A

5-Year Growth

N/A

10-Year Growth

N/A

Next Ex-Date

N/A

Next Payment

N/A

Last Ex-Date

Aug 29, 2024

Last Payment

N/A

Dividend History

Ex-Date	Payment Date	Amount	Type	Change
Aug 29, 2024	N/A	$19.3560	Cash	N/A

Payout Ratio (Earnings)

N/A

FCF Payout Ratio

N/A

Period	Revenue	Net Income	EPS	FCF
Q1 2026	$0.00	-$31.82M	$-0.58	-$23.65M
Q1 2025	$0.00	-$21.00M	$-0.50	-$20.88M
Q2 2025	$0.00	-$24.57M	$-0.58	-$23.18M
Q3 2025	$0.00	-$30.28M	$-0.69	-$21.70M

Buy: 0Hold: 6Sell: 0

Symbol	Company	Yield	Payout	Growth 5Y	Market Cap
REGN	Regeneron Pharmaceuticals, Inc.	0.48%	8.90%	N/A	$78.57B
TECH	Bio-Techne Corporation	0.44%	62.70%	0.00%	$11.29B
CNTA	Centessa Pharmaceuticals plc	93.84%	N/A	N/A	$3.51B
ESPR	Esperion Therapeutics, Inc.	99.37%	N/A	N/A	$661M
SVA	Sinovac Biotech Ltd.	3400.31%	N/A	N/A	$465M

About this data

Dividend data sourced from Financial Modeling Prep. Prices updated daily after market close.

Payout ratio — trailing 12-month dividends paid / trailing 12-month net income.

Consecutive years — calendar years with a higher total annual dividend than the prior year.

Growth rates — annualized, comparing the most recent full year total to the total N years prior.

For informational purposes only. Not investment advice.

Data as of August 5, 2026. Source: Financial Modeling Prep. Prices and yields updated daily after market close.